Skip to main content
Displaying 1 - 12 of 22
Display:
12
24
48
Liver Tumours
AstraZeneca: The evolving treatment landscape of advanced hepatobiliary cancers: expert insights and clinical case discussions...
Webcasts
View
Liver Tumours
Plenary: The expansion of immunotherapy-based combinations in HCC: unmet needs and scientific rationale
Webcasts
View
Liver Tumours
Panel discussion: Multidisciplinary management of patients across the HCC continuum: clinical perspectives and the evolution o...
Webcasts
View
Liver Tumours
Audience Q&A
Webcasts
View
Liver Tumours
Welcome and introductions
Webcasts
View
Liver Tumours
AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection (Complete Sess...
Webcasts
View
Liver Tumours
Panel discussion: Management of patients with HCC in the evolving landscape
Webcasts
View
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Introduction
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on Biochemical Normalization
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on QOL/Pruritus
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Conclusion
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy